What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone
- Written by James B. Rebitzer, Wexler Professor of Management, Economics and Public Policy, Boston University
Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform...